REPLY
16.3.2022 09:32:11 CET | Business Wire | Press release
Reply announced today that it has developed vjumi , an IoT solution that digitises the vehicle aftersales business and vehicle networking, for SELECT AG, leader in the automotive parts wholesale trade in Germany. The solution enables digital communication between the repair shop, the customer and the vehicle supplying independent workshops with their customers’ vehicle data in real time to prevent breakdowns and coordinate service appointments.
The focus of the solution developed by Reply is the connected vehicle, which sends the collected data to the cloud via mobile communications. The Azure-based cloud platform analyses and processes the vehicle data in real time and is fully integrated into the repair shops' customer systems. Communication with customers is enabled via a mobile app to guarantee a seamless data exchange between customer and repair shop.
Both customers and repair shops can easily use vjumi . Repair shops connect with their customers' vehicles and receive information about the condition of the vehicle via Real Time Diagnostics in order to proactively prevent breakdowns through Predictive Maintenance before they occur. In this way, repair shops optimise their service and offer customers increased safety.
Repair shop customers can use the app developed by Reply to monitor their vehicle data themselves. The vjumi app reminds of the next service appointment via push notification and coordinates the appointments directly with the repair shop. Drivers – or even fleet operators – benefit from a smooth, safe and comprehensive vehicle service, while avoiding unforeseen repairs.
"Whether it's a reminder of the next MOT appointment, an upcoming oil and brake service, or the option to contact the repair shop directly with an emergency call, vjumi provides a timely service in a secure cloud environment, taking into account all data protection regulations," comments Daniel Trost, CDO of Select AG.
Dr Thomas Hartmann, a member of the board of Reply, adds: "Digitalisation in the automotive sector will continue its unceasing march in the coming years, as our study on trends in the mobility sector shows. Our goal is to develop new concepts and technologies with IoT and AI, but also cloud platforms and comprehensive digital experience solutions. vjumi is one of the first fully integrated solutions in the sector and offers customers an all-round repair shop service – quasi on demand."
REPLY
Reply [MTA, STAR: REY, ISIN: IT0005282865] is specialised in the design and implementation of solutions based on new communication channels and digital media. Reply is a network of highly focused companies supporting key European industrial groups operating in the telecom and media, industry and services, banking, insurance and public administration sectors in the definition and development of business models enabled for the new paradigms of AI, cloud computing, digital media, and the Internet of Things. Reply services include: Consulting, System Integration and Digital Services. www.reply.com
SELECT AG
SELECT AG is a purchasing cooperation for the automotive parts wholesale trade. The core business is services for assortment, purchasing and sales support for the automotive parts wholesaler, and the associated independent repair shops. Founded in 2000, SELECT AG is now one of the three leading players in the German independent aftermarket (IAM). A total of 15 parts wholesalers belong to SELECT AG as shareholders with 142 ownership locations. Around 3,700 employees work for the shareholders of the purchasing association throughout Germany and support more than 31,000 customers. The annual turnover amounts to 800 million euros. www.select.ag
View source version on businesswire.com: https://www.businesswire.com/news/home/20220316005037/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC3.8.2026 03:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*. “As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.” The engagement highlights the breadth and scalability of SS&C’s global service model.
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom